Explore the latest deal across all financial deal types and actionable insights by Theme and Sector to support your business activities and workflows.

Japan: Five largest Private Equity/Venture Financing deals by value in the Healthcare sector (LTM June 2022)

  • A total of 81 Private Equity/Venture Financing deals (pending and completed) were announced in the Healthcare of Japan, in the last twelve months resulting in a total deal value of over $773.4 million. In the LTM period, May 2022 turned out to be the most prolific in terms of deal size, with a total deal value of $133.6 million, resulting in an average deal value of $13.4 million during that month. On the other hand, the month of May 2022 was the most prolific in terms of deal volume, recording a total of 10 deals, resulting in an average deal value of $13.4 million during that month.

  • Of the 81 deals, the deal secured between Globis Capital Partners & Co.; Incubate Fund; SoftBank Vision Fund 2; World Innovation Lab (WiL fund) and AI Medical Service Inc, was the largest Private Equity/Venture Financing deal in the Japan Healthcare sector, which was valued at $70.0 million and was completed on April 26, 2022. The second-largest deal was between Bain Capital Ventures LLC; DCM Ventures (Japan); Incubate Fund US L.P; Nissei Capital Co., Ltd; Pavilion Capital Partners LLC and Linc well Inc, while the third-largest deal was between SUMISEI INNOVATION FUND and FamiOne, Inc. The Bain Capital Ventures LLC; DCM Ventures (Japan); Incubate Fund US L.P; Nissei Capital Co., Ltd; Pavilion Capital Partners LLC-Linc well Inc deal and the SUMISEI INNOVATION FUND-FamiOne, Inc deal were valued at $69.4 million and $62.8 million, respectively. The fourth-largest deal was between Anri Fund; Catalys Pacific; GFC Global Founders Capital GmbH; HBM Healthcare Investments Ltd; SoftBank Vision Fund 2; Sumitomo Mitsui Trust Investment Co., Ltd.-Aculys Pharma LLC valued at $60.0 million, whereas the deal between Itochu Chemical Frontier Corp; Keio Innovation Initiative, Inc.; Medical Incubator Japan KK; MediPal Holdings Corp; Nissay Capital Co., Ltd.; SMBC Capital Co., Ltd.; Strategic Business Innovator Group; Sumitomo Mitsui Trust Holdings Inc; UTokyo Innovation Platform Co Ltd-Heartseed Inc valued at $36.5 million was the fifth-largest deal.

  • Cumulatively, the top five deals amounted to $298.8 million and accounted for nearly 38.63% of the total deals (by value) announced during the last twelve months.

Japan: Five largest Private Equity/Venture Financing deals by value in the Healthcare sector (LTM June 2022)

Published: June 2022
Source: GlobalData

Explore the latest deal across all financial deal types and actionable insights by Theme and Sector to support your business activities and workflows. Explore the latest deal across all financial deal types and actionable insights by Theme and Sector to support your business activities and workflows. Visit Report Store

Related Companies

Cencora Inc

United States of America

HCA Healthcare Inc

United States of America

Merck & Co Inc

United States of America

Pfizer Inc

United States of America

Providence St. Joseph Health

United States of America

Providence St. Joseph Health
Amgen Inc

United States of America

Highmark Health

United States of America

Highmark Health
Still looking?

Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.

Explorer

Access more premium companies when you subscribe to Explorer

Start of HubSpot Embed Code End of HubSpot Embed Code